Zurex Pharma secures $5.1M in financing
Zurex Pharma of Middleton received $5.1 million in investments, primarily from existing investors, including Baird Venture partners, the State of Wisconsin Investment Board, Peak Ridge Capital, and others. The company will use the money to help move its main product, ZuraPrep (a new type of disinfectant for cleaning skin prior to surgery) through clinical trials. Zurex has completed animal testing and is preparing its first clinical trials in June. The company, which currently has seven employees, would like to submit a new drug application to the FDA early in 2015.